Back
Oculis Holding AG Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
39
OCS
Oculis Holding AG
Last Price:
17.15
Seasonality Move:
10.14%
Sell
31
NLSP
NLS Pharmaceutics
Last Price:
1.94
Seasonality Move:
9.94%
Sell
39
Oculis Holding AG (OCS)
is a Sell
Is Oculis Holding AG a Buy, Sell or Hold?
- The current Oculis Holding AG [OCS] share price is $17.09. The Score for OCS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- OCS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $1.91. The Score for NLSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCS Stock Price Chart
What is Oculis Holding AG's stock price today?
-
The Oculis Holding AG share price today is $17.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OCS is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $1.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing selling pressure, which indicates risk of future bearish movement.
OCS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 66.29 | Buy |
Chaikin Money Flow: | -87468 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.76 - 16.3) | Buy |
Bollinger Bands (100): | (11.72 - 15.82) | Buy |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 23.76 | Sell |
Chaikin Money Flow: | -61833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.33 - 3.67) | Sell |
Bollinger Bands (100): | (3.34 - 6.94) | Sell |
OCS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.3 | Buy |
20-day SMA: | 15.58 | Buy |
50-day SMA: | 15.66 | Buy |
200-day SMA: | 12.8 | Buy |
8-day EMA: | 16.38 | Buy |
20-day EMA: | 15.95 | Buy |
50-day EMA: | 15.28 | Buy |
200-day EMA: | 13.3 | Buy |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.13 | Sell |
20-day SMA: | 2.81 | Sell |
50-day SMA: | 3.75 | Sell |
200-day SMA: | 6.26 | Sell |
8-day EMA: | 2.18 | Sell |
20-day EMA: | 2.72 | Sell |
50-day EMA: | 3.64 | Sell |
200-day EMA: | 8.38 | Sell |
Oculis Holding AG Earnings Growth & OCS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.13 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Oculis Holding AG Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |